Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1775 of 1863 entries
View as:

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00070096 Org: User:
Start: 08/31/03 End: 06/30/07 Due: 06/30/08

Short Course Daratumumab in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT03490344 Org: User:
Start: 05/03/18 End: 03/23/23 Due: 03/23/24

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02974647 Org: User:
Start: 11/30/16 End: 11/30/25 Due: 11/30/26

BGJ398 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT02257541 Org: User:
Start: 10/02/14 End: 03/25/19 Due: 03/25/20

BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder

Phase: N/A Priority: Normal
NCT ID: NCT02657486 Org: User:
Start: 01/31/16 End: 01/31/26 Due: 01/31/27

Humanized Anti-GD2 Antibody Hu3F8 and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02650648 Org: User:
Start: 01/31/16 End: 01/31/26 Due: 01/31/27

Study of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03810807 Org: User:
Start: 01/17/19 End: 01/31/26 Due: 01/31/27

Quality of Life in Patients Undergoing Total Pelvic Exenteration

Phase: N/A Priority: Normal
NCT ID: NCT00597805 Org: User:
Start: 01/31/05 End: 12/12/24 Due: 12/12/25

Novel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00721630 Org: User:
Start: 07/31/08 End: 07/31/16 Due: 07/31/17

Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00695851 Org: User:
Start: 03/31/05 End: 03/31/09 Due: 03/31/10

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05574101 Org: User:
Start: 10/06/22 End: 10/06/26 Due: 10/06/27

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT00715611 Org: User:
Start: 10/11/08 End: 07/31/25 Due: 07/31/26

Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine

Phase: N/A Priority: Normal
NCT ID: NCT00987480 Org: User:
Start: 09/25/09 End: 07/10/17 Due: 07/10/18

Melphalan, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed, Previously Untreated Primary Systemic Amyloidosis

Phase: N/A Priority: Normal
NCT ID: NCT00089167 Org: User:
Start: 05/31/02 End: - Due: -

3-D Reconstruction of CT Scan Images in the Evaluation of Non-Specific Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT00613041 Org: User:
Start: 04/30/03 End: 11/03/21 Due: 11/03/22

Negative Pressure Wound Therapy in Post-Operative Incision Management

Phase: N/A Priority: Normal
NCT ID: NCT02682316 Org: User:
Start: 02/29/16 End: 01/25/24 Due: 01/25/25

Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation

Phase: N/A Priority: Normal
NCT ID: NCT05659576 Org: User:
Start: 12/13/22 End: 12/31/25 Due: 12/31/26

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00014469 Org: User:
Start: 12/31/00 End: 05/31/07 Due: 05/31/08

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05787561 Org: User:
Start: 03/15/23 End: 03/31/26 Due: 03/31/27

Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03817814 Org: User:
Start: 01/18/19 End: 01/31/26 Due: 01/31/27

Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

Phase: N/A Priority: Normal
NCT ID: NCT04438824 Org: User:
Start: 06/17/20 End: 06/30/25 Due: 06/30/26

Mobile Health Device Study for Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03006315 Org: User:
Start: 12/31/16 End: 11/14/24 Due: 11/14/25

Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01484093 Org: User:
Start: 11/29/11 End: 08/11/23 Due: 08/11/24

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04238624 Org: User:
Start: 01/20/20 End: 06/20/25 Due: 06/20/26

A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT04872595 Org: User:
Start: 04/30/21 End: 04/30/26 Due: 04/30/27